University Of Oklahoma

This study tested two treatments—niraparib alone or niraparib plus bevacizumab—in people with recurrent endometrial or ovarian cancer that has a specific change in the ARID1A gene. The goal was to see how many patients' tumors shrank or disappeared. The study was stopped early af…

This study gave the drug acamprosate to people in DUI court who were dependent on alcohol. The goal was to see if the drug is safe and helps reduce cravings and prevent relapse. Only 4 people enrolled before the study was stopped, so we cannot draw firm conclusions.

This study looked at whether keeping blood sugar very tightly controlled (around 110 mg/dL) with continuous insulin could help people who had a stem cell transplant live longer and leave the hospital sooner. It compared this to a less strict approach (target 200 mg/dL). The study…

This study tested a new imaging device called MSOT that uses light and sound to detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. About 29 adults took part to see if the scan is safe and can spot inflammation in the skin or gut. The goal w…

This study tested a wearable device that uses gentle vibrations to help stroke survivors improve arm strength and movement. The plan was to have 48 people use the device at home for 4 weeks, but only 4 enrolled before the study was stopped. Researchers measured usability and chan…